User's Guide

LooK SPOT reader user’s guide
For Use Under the Emergency Use Authorization (EUA) Only
For in vitro Use Only
For use with nasal swab specimens
Rx Only
INTENDED USE
LooK SPOT is a smartphone-based reader to detect the COVID-19 antigen using LooK COVID-19 antigen
cassette based on lateral flow immunoassay. LooK SPOT and LooK COVID-19 antigen cassettes use the
qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in nasal swabs from patients
suspected of COVID-19 within the first seven (7) days of symptom onset. The reagent is used to detect the
SARS-CoV-2 nucleocapsid protein antigen, which is usually present in the respiratory tract specimens in the
acute phase of infection. The test result is obtained by inserting the LooK COVID-19 antigen cassette into the
smartphone-based LooK SPOT reader.
When a positive result is presented, it means that there are viral antigens in the specimen, but the patient's
medical history must be combined with other clinical data to assess the infection status; a positive result
cannot exclude bacterial infection or co-infection with other viruses, and the detected pathogen may not be
the main reason of the disease.
Negative results cannot completely rule out SARS-CoV-2 infection, so this product should not be used as the
only basis for treatment or management decisions (including infection control); negative results should be
comprehensively evaluated based on the patient's contact history, medical history, signs and clinical
symptoms, necessary at times, molecular diagnosis (RT-PCR) is used to confirm the diagnosis and serve as a
basis for patient management. The LooK COVID-19 antigen cassette does not differentiate between SARS-
CoV and SARS-CoV- 2.
LooK COVID-19 antigen rapid test is for use at the Point of Care (POC) settings by medical or trained
professionals who perform rapid lateral flow tests. It is only for use under the Food and Drug
Administration's Emergency Use Authorization.
SUMMARY
The SARS-CoV-2 virus is a positive-stranded single-stranded RNA virus with an envelope with a virus particle
diameter of about 50200nm; it is composed of four main structural proteins: spike protein (S), envelope
protein (E), membrane protein (M) and nucleocapsid protein (N). The nucleocapsid protein binds to the viral
RNA, and the other three proteins together form the viral coat. Its gene sequence is similar to SARS and
MERS viruses, but they belong to different species.
The incubation period of the SARS-CoV-2 is about 2-14 days on average; most patients will have respiratory
symptoms. Typical symptoms include frequent fever, dry cough, weakness of limbs, etc. (may be
accompanied by muscle pain, diarrhea, sore throat, loss of smell and abdominal pain, etc.). There is a
percentage of carriers without any clinical symptoms. Severe patients may develop acute respiratory distress
syndrome (ARDS), septic shock, diffuse alveolar injury, or even death. SARS-CoV-2 virus has spread globally.
LooK COVID-19 antigen rapid test is an immunochromatographic test that uses monoclonal antibodies
combined with latex particles to detect whether there are SARS-CoV-2 antigens in nasal secretions. This
reagent is not only easy to execute, and the test result can be ready within five (5) minutes with the use of
LooK SPOT reader and a smartphone with LooK SPOT app.

Summary of content (15 pages)